RNA – avidity biosciences, inc. (US:NASDAQ)

News

Avidity Biosciences Announces Expected Record Date for Spin-Off [Yahoo! Finance]
Avidity Biosciences Announces Expected Record Date for Spin-Off
Avidity Biosciences (NASDAQ:RNA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]
SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com